State Street Health Care Select Sector SPDR ETF
Loading news...
If you are an investor who is securing profits and is buying up dividend ETFs to weather a possible downturn instead, it's not a bad idea to look back at the past and see which ones have outperformed.
Wall Street eyes a bullish 2026 as GDP looks likely to accelerate, AI mania continues and earnings solidify. ETFs like RSP, XLV and XSW come into focus.
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.
The stock market has enjoyed a remarkable run over the past 12 months. Driven by a successful soft landing engineered by the Federal Reserve and the initial excitement surrounding generative artificial intelligence (AI), 2025 rewarded risk-taking.
The Federal Reserve will conclude its most contentious FOMC meeting of the year this afternoon, and the outcome has the potential to meaningfully sway markets. There is a real possibility this turns into a “sell the news” event, but if that happens, I also see several areas where investors may want to consider rotating.
With market tailwinds building and optimism returning, these top-ranked ETFs can help investors capture momentum safely.
The H ealth Care Select Sector SPDR is comprised of all the Health Care stocks inside the S&P 500 Index. Its expense ratio is only 0.08% and XLV has $41.2B in AUM. The simple case for overweighting U.S. Health Care is that XLV currently features a unique combination of a low beta, moderate growth, and excellent momentum and sentiment. XLV also offers terrific growth-at-a-reasonable-price features, but only on a forward basis. A GARP analysis based on historical metrics highlights an interesting divide worth watching.
November muted for markets, but ETFs like SPYM, BWET, WNTR, LITP and OZEM stand out.
State Street Investment Management (SSIM) has been the investment advisor for the Select Sector SPDR ETFs since 1998. It will now take over the distribution and marketing for these funds.
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories.
Stocks rallied on rising Fed rate cut bets for December, with Alphabet hitting $4T and health care, auto sectors showing renewed strength.
Stocks were mainly higher at midday as Wall Street traded higher ahead of the Thanksgiving holiday. Investors are likely optimistic as markets enter what is typically the strongest stretch of the year for corporate sales.
Vanguard Health Care ETF and Health Care Select Sector SPDR Fund both benefit from healthcare innovation tailwinds, earning a buy rating. VHT offers broader diversification and greater exposure to small-caps and biotechs, providing stronger upside potential compared to XLV's mega-cap pharma focus. XLV's concentrated portfolio delivers higher dividend yield and stability, but exposes investors to greater idiosyncratic risk from top holdings like LLY.
Wall Street's sector rotation entered full throttle Tuesday, with investors pouring into previously overlooked corners of the market amid an AI-driven shift that now favors undervalued small caps and defensive names such as health care.
GLD gains attention as AI bubble fears rise, with investors eyeing hedges and ETFs geared toward market downside protection.
LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.
Amid rising AI bubble fears, ETFs like TAIL, HDGE, PGHY and XLV offer ways to hedge tech risks and diversify portfolios as tech valuations apparently run hot.
Step aside tech stocks in the S&P 500. Health care stocks are taking over a leadership role — although it might be short-lived.
Health Care Select Sector SPDR Fund (NYSEARCA:XLV - Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock investors purchased 55,635 put options on the company. This represents an increase of 168% compared to the typical volume of 20,759 put options. Health Care Select Sector SPDR Fund Price Performance NYSEARCA
The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in the Russell 1000 universe with positive recent consensus revisions to 2026 EPS estimates and that trade at attractive valuations. Goldman sees "more opportunity for alpha than beta" as wide return dispersion and increasing M&A activity in healthcare may favor selected winners.